跳至主要内容
临床试验/IRCT2013072314121N1
IRCT2013072314121N1已完成未知

Conversion of continuous infusion of regular insulin to subcutaneous glargine insulin for regulating blood glucose in patients receiving TPN: A method development study.

Deputy of Research, Tehran University of Medical Sciences0 个研究点目标入组 28 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • with the consent of the patient or the qualified relatives; aged over 18 years; patients who are NPO for at least 7 days or more candidates for receiving PN. Exclusion criteria: autoimmune diseases, HIV infection and sepsis; diabetes mellitus; pregnancy; on dialysis or GFR < 10 mL/min (due to the pharmacokinetics of insulin); any hypersensitivity to PN components or insulin glargine; receiving corticosteroids, catecholamines, or getting PO.

排除标准

  • 未提供

研究者

发起方
Deputy of Research, Tehran University of Medical Sciences

相似试验

Application of a long acting insulin (glargine) in... | 临床试验